About Logos
Logos is a private equity firm founded in 2007.ÌýIt is primarily based in San Francisco, United States.ÌýIn the last 12 months, it has participated in 8 funding rounds.Ìý
Overall Logos portfolio has seen 1 unicorn, 45 IPOs and 11 acquisitions including key companies like C4 Therapeutics, ALX Oncology and Ikena Oncology.ÌýA lot of funds co-invest with Logos, with names like Janus Henderson Investors sharing a substantial percentage of its portfolio.Ìý
Logos has a team of 9 people, including 4 partners.
Key Metrics
Founded Year
2007
Location
San Francisco, United States
Investment Deals
C4 Therapeutics, ALX OncologyÌý&²¹³¾±è;Ìý
Logos' Portfolio
They have invested in a total of 89 companies. Their most recent investment was in Verdiva Bio (Series A round) on Jan 09, 2025.Team profile of Logos
Logos has a team of 9 membersÌý¾±²Ô³¦±ô³Ü»å¾±²Ô²µ 4 Partners and 4 PrincipalsÌýlocated in United States. Logos' team does not sit on the board of any company as of now.Here is a list of all team members in Logos:
Name | Designation | Location | Board Memberships | Contact details |
|---|---|---|---|---|
Partner | San Francisco | - | ||
Partner | San Francisco | - | ||
Partner | San Francisco | - | ||
Partner | - | - | ||
Principal | Los Angeles | - | ||
Principal | San Francisco | - | ||
Principal | San Francisco | - | ||
Principal | - | - | ||
Analyst | New York City | - |
Co-investors of Logos
Over the past 18 years, 228 investors have co-invested in Logos's portfolio companies.
- Top Co-investors of Logos:Ìý228 investors entered a company along with Logos. These include investors like Janus Henderson Investors (36 companies).
Logos News
•
•
•
BioSpace•Jan 09, 2025•Verdiva Bio, Forbion, General Atlantic, RA Capital Management and 4 others
•
Pharmaceutical Technology•Jan 09, 2025•Verdiva Bio, Forbion, General Atlantic, RA Capital Management and 4 others
•
Business Wire•Jan 07, 2025•Aviceda Therapeutics, Omega Funds, TCG Crossover, Enavate Sciences and 9 others
•
•
PR Newswire•Dec 16, 2024•Trevi Therapeutics, Adage Capital Management, Frazier Life Sciences, Logos and 6 others
•
Pharmaceutical Technology•Dec 04, 2024•Maze Therapeutics, Deep Track Capital, Frazier Life Sciences, Logos and 7 others
•
Fierce Biotech•Dec 03, 2024•Maze Therapeutics, Frazier Life Sciences, Deep Track Capital, Janus Henderson Investors and 4 others
•
Business Wire•Dec 03, 2024•Maze Therapeutics, Frazier Life Sciences, Deep Track Capital, Logos and 15 others
Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies- 212K+ Investors
- 580K+ Funding Rounds
- 207K+ Acquisitions
- 2.9K+ Sectors
- 57K+ Business Models
